Articles

Find an Article

Filter articles

Showing 41 to 50 of 692 results

The future of precision medicine part 6: reimbursement

International08-08-2019Daniel Lim

In future, the more efficient targeting of treatments to specific patient populations that will actually benefit from them, could offset the price of more expensive but well targeted and effective treatments that will be suitable for increasingly smaller patient populations. Daniel Lim and Anna Jackson of Kirkland & Ellis explain.

The future of precision medicine part 5: keeping pace with regulation

International26-07-2019Daniel Lim

One of the perennial inherent challenges for legislators and regulators is crafting laws and regulatory frameworks that are firm enough to deal with the issues of the present, but flexible enough to cater for the challenges of the future, as Daniel Lim and Anna Jackson of Kirkland & Ellis explain.

Conference preview: Women Leaders in Life Sciences Law

US26-06-2019

The next event in ACI’s Women Leaders in Law series, on July 25 & 26 in Boston, brings together in-house and private practice professionals from the pharmaceutical, biotechnology, and medical device industries.

C5’s 18th International forum on Pharmaceutical Patent Term Extensions

EU, Germany04-06-2019

European legislators and patent offices, and in-house pharma decision-makers will tackle current patent term extension challenges on June 25 & 26 at the Maritim Hotel München, Munich.

Precision medicine: The personal touch

21-05-2019

Precision medicine is an evolving field, which takes individual variability in genes, environment, and lifestyle into account when tackling disease treatment and prevention. LSIPR reports.

Shire Pharmaceuticals: A culture of excellence

Ireland, Japan21-05-2019

LSIPR provides a look behind the scenes of Shire Pharmaceuticals, the Irish company valued at £46 billion by its acquirer Takeda.

Women in STEM: Bridging the gender gap

21-05-2019

A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.

Marketing authorisation: Splitting the bill

US20-05-2019Mark Remus

An increasing number of pharmaceutical companies are turning to joint representation—where they pool their funds and hire one firm to represent them all—for ANDA litigation. Mark Remus, shareholder at Brinks Gilson & Lione, outlines the pros and cons of this new direction.

SPCs: extending protection lifespan

UK20-05-2019Michael Pears and Joel Beevers

Two references to the Court of Justice of the European Union should help clarify the position on what exactly is eligible for a supplementary protection certificate, as Michael Pears and Joel Beevers of Potter Clarkson explain.

The heart of the 3D printing matter

US20-05-2019Gabriel Di Blasi

3D-printed organs and tissues are now a reality, but questions remain over their patentability, says Gabriel Di Blasi of Di Blasi, Parente & Associados.

Showing 41 to 50 of 692 results

LSIPR